Anti-hypoxic effect of ginsenoside Rbl on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo

Abstract

Aim: The aim of this study was to investigate whether Gs-Rbl relieves the CoCl 2-induced apoptosis of hypoxic neonatal rat cardiomyocytes and in which the role of glucose transporter-4 (GLUT-4). Methods: Gs-Rbl (0, 10, 50, 100, 200, 400, and 500 mol/L), adenine 9-Β-D-arabinofuranoside (ara A, 500 mol/L; AMPK inhibitor) and wortmannin (0.5 mol/L; PI3K inhibitor) only in combination with 200 mol/L Gs-Rbl were administered in hypoxic cardiomyocytes, which were induced by 500 mol/L CoCl 2 for 12 h. Then, the apoptotic rate (AR), 2-[ 3 H]-deoxy-D-glucose (2-[ 3 H]-DG) uptake, and the expression of GLUT-4 (including in plasma membrane, PM), phospho-AMPKα (Thr172), AMPKα and Akt in cells were assayed. Results: Compared with simple hypoxia (0 mol/L Gs-Rbl), Gs-Rb1 greater than 10 mol/L significantly decreased the apoptotic rate (P0.01) and significantly increased 2-[ 3 H]-DG uptake (P0.01), GLUT-4 content in cells and PM (P0.01), AMPK activity (P0.01) and Akt (P0.01) levels in a dose-dependent manner. AMPK activity was completely suppressed by ara-A, just as Akt was suppressed by wortmannin. The AR, glucose uptake and GLUT-4 levels in cells and PM were partly down-regulated by ara-A or wortmannin. Conclusion: Gs-Rb1 may protect neonatal rat cardiomyocytes from apoptosis induced by CoCl 2. The anti-apoptotic effect of Gs-Rb1 may occur by improving glucose uptake, in which GLUT-4 translocation and expression played a key role. Both the AMPK and the PI3K/Akt pathways may take part in the anti-hypoxic efficacy of Gs-Rb1. © 2009 CPS and SIMM.